Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Oncology Reports
Published in: Current Oncology Reports 2/2012

01-04-2012 | Head and Neck Cancers (EY Hanna, Section Editor)

Current Progress in Adaptive Radiation Therapy for Head and Neck Cancer

Author: David L. Schwartz

Published in: Current Oncology Reports | Issue 2/2012

Login to get access

Abstract

Head and neck intensity-modulated radiotherapy (IMRT) remains toxic, and cannot compensate for anatomic changes or tumor response that occur during treatment. Adaptive radiotherapy (ART) is a novel approach to correct for variations in geometry of tumor and bystander anatomy with repeated imaging-based modification of treatment delivery. Technical limitations have hampered introduction of ART into routine practice. This review summarizes investigational challenges impacting development of head and neck ART, describes findings from early clinical testing of an automated ART platform, and highlights emerging directions of ongoing research.
Literature
1.
Sobel S, Rubin P, Keller B, Poulter C. Tumor persistence as a predictor of outcome after radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys. 1976;1(9–10):873–80.PubMed
2.
Barkley HT, Fletcher GH. The significance of residual disease after external irradiation of squamous-cell carcinoma of the oropharynx. Radiology. 1977;124(2):493–5.PubMed
3.
Suit HD, Walker AM. Assessment of the response of tumours to radiation: clinical and experimental studies. Br J Cancer Suppl. 1980;41 Suppl 4:1–10.
4.
Trott KR. Human tumour radiobiology: clinical data. Strahlentherapie. 1983;159(7):393–7.PubMed
5.
Bhide SA, Davies M, Burke K, et al. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. Int J Radiat Oncol Biol Phys. 2010;76(5):1360–8.PubMedCrossRef
6.
• Barker JL, Jr., Garden AS, Ang KK, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys. 2004;59(4):960–70. A seminal study utilizing serial in-room CT imaging to catalog volumetric and positional tissue changes occurring during a course of H&N IMRT treatment, particularly changes involving parotid glands and tumor volumes. PubMedCrossRef
7.
Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127–36.PubMedCrossRef
8.
Hansen EK, Bucci MK, Quivey JM, et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;64(2):355–62.PubMedCrossRef
9.
Mohan R, Zhang X, Wang C, et al. Deforming intensity distributions to incorporate inter-fraction anatomic variations for image-guided IMRT. Int J Radiat Oncol Biol Phys. 2004;60(1):S226–S7.CrossRef
10.
Court LE, Dong L, Lee AK, et al. An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. Int J Radiat Oncol Biol Phys. 2005;62(1):154–63.PubMedCrossRef
11.
Court LE, Tishler RB, Petit J, et al. Automatic online adaptive radiation therapy techniques for targets with significant shape change: a feasibility study. Phys Med Biol. 2006;51(10):2493–501.PubMedCrossRef
12.
Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003;69(3):227–36.PubMedCrossRef
13.
Chao KSC, Bhide S, Chen H, et al. Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phys. 2007;68(5):1512–21.PubMedCrossRef
14.
Gregoire V, De Neve W, Eisbruch A, et al. Intensity-modulated radiation therapy for head and neck carcinoma. Oncologist. 2007;12(5):555–64.PubMedCrossRef
15.
Eisbruch A, Gregoire V. Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer. Semin Radiat Oncol. 2009;19(1):43–52.PubMedCrossRef
16.
Nangia S, Chufal KS, Tyagi A, et al. Selective nodal irradiation for head and neck cancer using intensity-modulated radiotherapy: application of RTOG consensus guidelines in routine clinical practice. Int J Radiat Oncol Biol Phys. 2009.
17.
Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45(3):577–87.PubMedCrossRef
18.
Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys. 2001;49(4):907–16.PubMedCrossRef
19.
Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007;68(5):1289–98.PubMedCrossRef
20.
Schwartz DL, Hutcheson K, Barringer D, et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78(5):1356–65.PubMedCrossRef
21.
Chao KS, Majhail N, Huang CJ, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol. 2001;61(3):275–80.PubMedCrossRef
22.
Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53(1):12–22.PubMedCrossRef
23.
Eisbruch A, Rhodus N, Rosenthal D, et al. The prevention and treatment of radiotherapy-induced xerostomia. Semin Radiat Oncol. 2003;13(3):302–8.PubMedCrossRef
24.
Hong TS, Tome WA, Chappell RJ, et al. The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005;61(3):779–88.PubMedCrossRef
25.
Prisciandaro JI, Frechette CM, Herman MG, et al. A methodology to determine margins by EPID measurements of patient setup variation and motion as applied to immobilization devices. Med Phys. 2004;31(11):2978–88.PubMedCrossRef
26.
Gregoire V, Daisne JF, Geets X, Levendag P. Selection and delineation of target volumes in head and neck tumors: beyond ICRU definition. Rays. 2003;28(3):217–24.PubMed
27.
Manning MA, Wu Q, Cardinale RM, et al. The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(5):1400–9.PubMedCrossRef
28.
Hatherly KE, Smylie JC, Rodger A, et al. A double exposed portal image comparison between electronic portal imaging hard copies and port films in radiation therapy treatment setup confirmation to determine its clinical application in a radiotherapy center. Int J Radiat Oncol Biol Phys. 2001;49(1):191–8.PubMedCrossRef
29.
Bel A, Keus R, Vijlbrief RE, Lebesque JV. Setup deviations in wedged pair irradiation of parotid gland and tonsillar tumors, measured with an electronic portal imaging device. Radiother Oncol. 1995;37(2):153–9.PubMedCrossRef
30.
Willner J, Hadinger U, Neumann M, et al. Three dimensional variability in patient positioning using bite block immobilization in 3D-conformal radiation treatment for ENT-tumors. Radiother Oncol. 1997;43(3):315–21.PubMedCrossRef
31.
Karger CP, Jakel O, Debus J, et al. Three-dimensional accuracy and interfractional reproducibility of patient fixation and positioning using a stereotactic head mask system. Int J Radiat Oncol Biol Phys. 2001;49(5):1493–504.PubMedCrossRef
32.
Li H, Zhu XR, Zhang L, et al. Comparison of 2D radiographic images and 3D cone beam computed tomography for positioning head-and-neck radiotherapy patients. Int J Radiat Oncol Biol Phys. 2008;71(3):916–25.PubMedCrossRef
33.
Court L, Rosen I, Mohan R, Dong L. Evaluation of mechanical precision and alignment uncertainties for an integrated CT/LINAC system. Med Phys. 2003;30(6):1198–210.PubMedCrossRef
34.
Jaffray DA, Drake DG, Moreau M, et al. A radiographic and tomographic imaging system integrated into a medical linear accelerator for localization of bone and soft-tissue targets. Int J Radiat Oncol Biol Phys. 1999;45(3):773–89.PubMedCrossRef
35.
Kuriyama K, Onishi H, Sano N, et al. A new irradiation unit constructed of self-moving gantry-CT and linac. Int J Radiat Oncol Biol Phys. 2003;55(2):428–35.PubMedCrossRef
36.
Mackie TR, Kapatoes J, Ruchala K, et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56(1):89–105.PubMedCrossRef
37.
Ahn PH, Ahn AI, Lee CJ, et al. Random positional variation among the skull, mandible, and cervical spine with treatment progression during head-and-neck radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73(2):626–33.PubMedCrossRef
38.
Zhang L, Garden AS, Lo J, et al. Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2006;64(5):1559–69.PubMedCrossRef
39.
van Kranen S, van Beek S, Rasch C, et al. Setup uncertainties of anatomical sub-regions in head-and-neck cancer patients after offline CBCT guidance. Int J Radiat Oncol Biol Phys. 2009;73(5):1566–73.PubMedCrossRef
40.
Lee C, Langen KM, Lu W, et al. Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registration. Radiother Oncol. 2008;89(1):81–8.PubMedCrossRef
41.
Wang ZH, Yan C, Zhang ZY, et al. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study. Laryngoscope. 2009;119(10):1966–74.PubMedCrossRef
42.
Geets X, Daisne JF, Arcangeli S, et al. Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI. Radiother Oncol. 2005;77(1):25–31.PubMedCrossRef
43.
Lu W, Chen ML, Olivera GH, et al. Fast free-form deformable registration via calculus of variations. Phys Med Biol. 2004;49(14):3067–87.PubMedCrossRef
44.
Wang H, Dong L, O’Daniel J, et al. Validation of an accelerated ‘demons’ algorithm for deformable image registration in radiation therapy. Phys Med Biol. 2005;50(12):2887–905.PubMedCrossRef
45.
Castadot P, Lee JA, Parraga A, et al. Comparison of 12 deformable registration strategies in adaptive radiation therapy for the treatment of head and neck tumors. Radiother Oncol. 2008;89(1):1–12.PubMedCrossRef
46.
Zhang T, Chi Y, Meldolesi E, Yan D. Automatic delineation of on-line head-and-neck computed tomography images: toward on-line adaptive radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68(2):522–30.PubMedCrossRef
47.
Nithiananthan S, Brock KK, Daly MJ, et al. Demons deformable registration for CBCT-guided procedures in the head and neck: convergence and accuracy. Med Phys. 2009;36(10):4755–64.PubMedCrossRef
48.
O’Daniel JC, Garden AS, Schwartz DL, et al. Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? Int J Radiat Oncol Biol Phys. 2007;69(4):1290–6.PubMedCrossRef
49.
Lee C, Langen KM, Lu W, et al. Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. Int J Radiat Oncol Biol Phys. 2008;71(5):1563–71.PubMedCrossRef
50.
•• Wu Q, Chi Y, Chen PY, et al. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys. 2009;75(3):924–32. This is among the most thorough preclinical H&N ART studies yet published. The authors comprehensively catalog and compare the potential impact of different clinically relevant adaptive strategies, including the potential dosimetric effects of alternative frequency and timing of ART replanning events. PubMedCrossRef
51.
Ahunbay EE, Peng C, Godley A, et al. An on-line replanning method for head and neck adaptive radiotherapy. Med Phys. 2009;36(10):4776–90.PubMedCrossRef
52.
Madani I, Duthoy W, Derie C, et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68(1):126–35.PubMedCrossRef
53.
Vanderstraeten B, Duthoy W, De Gersem W, et al. [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radiother Oncol. 2006;79(3):249–58.PubMedCrossRef
54.
Lee N, Nehmeh S, Schoder H, et al. Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009;75(1):101–8.PubMedCrossRef
55.
• Dirix P, Vandecaveye V, De Keyzer F, et al. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med. 2009;50(7):1020–7. This report shares results from an exciting proof-of-concept trial employing “brute force” multimodality functional imaging for biologically informed dose painting by numbers. Although this degree of image-based characterization is currently not feasible outside of experienced research centers, the manuscript provides potential insight into the future of image-guided H&N ART. PubMedCrossRef
Metadata
Title
Current Progress in Adaptive Radiation Therapy for Head and Neck Cancer
Author
David L. Schwartz
Publication date
01-04-2012
Publisher
Current Science Inc.
Published in
Current Oncology Reports / Issue 2/2012
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-012-0221-4

Other articles of this Issue 2/2012

Current Oncology Reports 2/2012 Go to the issue

Evolving Therapies (RM Bukowski, Section Editor)

PI3K and mTOR Signaling Pathways in Cancer: New Data on Targeted Therapies

Pediatric Oncology (S Epelman, Section Editor)

Targeted Therapy in Bone and Soft Tissue Sarcoma in Children and Adolescents

Pediatric Oncology (S Epelman, Section Editor)

Late Effects in Cancer Survivors: “The Shared Care Model”

Pediatric Oncology (S Epelman, Section Editor)

Impact of Molecular Biology Studies on the Understanding of Brain Tumors in Childhood

Evolving Therapies (RM Bukowski, Section Editor)

RET TKI: Potential Role in Thyroid Cancers

Retraction Note

Erratum to: New Drug Developments for Patients with Metastatic Soft Tissue Sarcoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits